[
  {
    "ts": "2025-12-04T12:39:00+00:00",
    "headline": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
    "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
    "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2e332b71-3833-3572-a4df-6abc427e0a3e",
      "content": {
        "id": "2e332b71-3833-3572-a4df-6abc427e0a3e",
        "contentType": "STORY",
        "title": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
        "description": "",
        "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
        "pubDate": "2025-12-04T12:39:00Z",
        "displayTime": "2025-12-04T12:39:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T08:00:00+00:00",
    "headline": "BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?",
    "summary": "The company’s chief medical officer discusses its trajectory with the blockbuster Brukinsa and its strong hematology pipeline.",
    "url": "https://www.pharmavoice.com/news/beone-blood-cancer-brukinsa-sonrotoclax-leukemia-lymphoma/807019/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "23bb2376-e22c-3722-a890-f4c363360351",
      "content": {
        "id": "23bb2376-e22c-3722-a890-f4c363360351",
        "contentType": "STORY",
        "title": "BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?",
        "description": "",
        "summary": "The company’s chief medical officer discusses its trajectory with the blockbuster Brukinsa and its strong hematology pipeline.",
        "pubDate": "2025-12-04T08:00:00Z",
        "displayTime": "2025-12-04T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "PharmaVoice, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/faCzssBpuaIVME6M0juLqw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CqL3QO_OKFjlEPfzRSbRjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/beone-blood-cancer-brukinsa-sonrotoclax-leukemia-lymphoma/807019/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beone-brought-brukinsa-blood-cancer-080000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]